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1. Introduction 
Using a cell-free protein-synthesizing system pre- 
pared from rat liver, we [ 1,2] obtained evidence that 
cycloheximide inhibits translocation of peptidyl-tRNA 
from the aminoacyl (A) site to the peptidyl (P) site on 
the ribosome, a reaction that requires transferase II 
(translocase) and GTP. To confirm this in a simpler 
system, we have exploited the reaction of 3H-puromycin 
with peptidyl-tRNA. Formation of peptidyl-puromycin, 
which is catalyzed by the peptidyl-transferase activity 
of the ribosome, only occurs when the peptidyl-tRNA 
is in the P position on the ribosome [3] . Consequently, 
peptidyl-tRNA present at the A position has first to 
be translocated to the P position by transferase II be- 
fore it can react with puromycin. In this way we have 
demonstrated that cycloheximide and fusidic acid in- 
hibit the reaction of puromycin with peptidyl-tRNA 
in the A position but not in the P position. This 
implies that translocation is affected by both of these 
inhibitors. In contrast, emetine does not inhibit the 
puromycin reaction with either population of ribo- 
somes. While this work was in progress, McKeehan 
and Hardesty [4] published results obtained with 
reticulocyte polysomes that agree with our identifica- 
tion of the site of cycloheximidine inhibition. 
2. Methods 
Polysomes, prepared from livers of fasting 150 g 
rats [5], were further purified by centrifugation 
through a discontinuous sucrose gradient consisting 
of 4 ml of 0.5 M sucrose and 4 ml of 2 M sucrose, each 
North-Holland Publishing Company - Amsterdam 
made up in 50 mM tris-HCl pH 7.6, KC1 25 mM, 
MgCI;! 5 mM (T,KM buffer) containing 0.5 M NH&l. 
Transferases I and II were resolved from liver cell sap 
by the method of Gasior and Moldave [6] . The pro- 
tein content of the polysomes and enzymes was 
measured by the Lowry procedure [7] . 
The assay for formation of peptidyl puromycin 
contained, in a total volume of 0.5 ml of 50 mM tris- 
HCl buffer pH 7.6,5 mM MgC12, 300 mM NH&I, 
0.15 to 0.25 mg of purified polysomes and 0.5 
wmoles of 3H-puromycin (3 X 16 cpm) purchased 
from New England Nuclear Corporation. After in- 
cubation, an equal volume of 10% TCA was added 
and the mixture was heated at 90” for 15 min. The 
precipitates were collected on glass fiber filters, wash- 
ed with 5% TCA and then 90% ethanol, and dried. 
The precipitates with filters were digested in scintilla- 
tion vials with 0.5 ml Nuclear Chicago Solubiliser at 
55” for 30 min, and counted in a toluene-based solu- 
tion in the Beckman IS-150 scintillation counter. 
Incubation mixtures for sedimentation analysis of 
polysome profiles were first diluted with 0.7 vol. of 
0.0 1 M tris-HCI buffer pH 7.5, then layered’over a 
linear gradient of 10 to 50% sucrose in TKM buffer. 
The gradient was centrifuged at 38,000 rpm in the 
SW-50 rotor of Spinco Model L-2 ultracentrifuge for 
70 min. The absorption profile at 260 rrqu was recorded 
automatically with a flow cell device in a Gilford 
model 2000 spectrophotometer. Radioactivity on the 
gradient was measured on fractions of 12 drops; the 
protein was precipitated with carrier albumin and the 
hot trichloroacetic acid insoluble material was collected 
on a glass fiber filter and counted as described above. 
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3. Results and discussion 
Rat liver polysomes, washed by one passage through 
a discontinuous 0.5 M and 2 M sucrose gradient contain- 
ing 0.5 M NH4C1 , were incubated with 3H-puromycin. 
The puromycin continued to react with the peptidyl- 
tRNA on the ribosomes at a diminishing rate for at least 
60 rain (fig. 1), to give a final uptake of about 40 ##moles 
per mg of  ribosomes. The reaction was only moderately 
dependent on addition of GTP to the medium. This in- 
dicates that the ribosomes till had significant amounts 
of adhering GTP and transferase II, since Skogerson and 
Moldave [7] who used rat liver ribosomes repeatedly 
washed in NH4C1 found them to be considerably de- 
pendent on added GTP and transferase II for reaction 
with puromycin. This allowed the peptidyl-tRNA to 
migrate from the aminoacyl position to the peptidyl 
position on the ribosome where it then reacted with 
the puromycin. 
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Fig. 1. Rate of synthesis of puromycin peptide by liver poly- 
somes in the presence and absence of transferase II and GTP. 
The incubation mixture (0.5 ml) contained buffer, 0.6 mg 
polysomes and 0.5 mtzmole aH-puromycin (3X 105 cpm) 
• o . , and was incubated at 37 fo r  various t~mes. 
When the reaction products were resolved on a 
linear sucrose gradient (fig. 2), incubation with 
3H-puromycin in the absence of antibiotics resulted 
in release of most of the 3H-puromycin peptide to 
the top of the gradient. The reaction and particularly 
the release was inhibited almost completely by spar- 
somycin, a known antagonist of peptide bond forma- 
tion by peptidyl transferase [6]. High concentrations 
of cycloheximide were also inhibitory, whereas 
EFFECT OF EMETINE, SPARSOMYCIN AND 
CYCLOHEXIMIDE ON PUROMYCIN-DEPENDENT RELEASE 
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Fig. 2. Effect of cycloheximide, sparsomycin, and emetine on 
puromycin peptide formation. The incubation mixture (0.5 
ml) containing polysomes was preincubated at 37 ° for 3 min 
with either sparsomycin (2 ug/ml), cycloheximide (1 mg/ml) 
or emetine (100 ug/ml). A control tube was also preincubated 
without any addition. After the preincubation, each tube re- 
ceived 0.5 m#mole of 3H-puromycin (3 X l0 s cpm), and was 
incubated for a further 5 min. The reaction products were sub- 
jected to sucrose gradient resolution. Each diagram shows the 
polysome profile ( ) and the amount of radioactivity 
(o-----0) along the gradient. 
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Fig. 3. Effect of fusidic acid (600 rg/ml) on puromycin peptide formation. (See legend to fig. 2 for incubation conditions). 
emetine was ineffective. Finally, fusidic acid acted like 
cycloheximide in being partially inhibitory (fig. 3). 
The freshly harvested ribosomes generally have some 
20% of the peptidyl-tRNA at the peptidyl position on 
the ribosomes [7] which can react directly with puro- 
mycin. The remaining 80% of ribosomes have the pep- 
tidyl-tRNA at the aminoacyl position and require 
translocation to the peptidyl position before reaction 
with puromycin. If cycloheximide and fusidic acid act 
on the translocation step, this would explain why they 
exert an extensive but not complete inhibitory effect 
on 3H-puromycin peptide formation (fig. 2). If this is 
correct, these inhibitors should no longer be effective 
when all the peptidyl-tRNA is at the peptidyl site. 
Accordingly, we preincubated the polysomes briefly 
before applying these antibiotics; as indicated above, 
the polysomes are contaminated with enough trans- 
ferase II and GTP to allow translocation from the 
aminoacyl to the peptidyl site to take place (fig. 1). 
Addition of cycloheximide or fusidic acid after this 
preliminary incubation failed to inhibit puromycin 
peptide synthesis, whereas control tubes not prein- 
cubated showed inhibition (table 1). In contrast, spar- 
Table 1 
The effect of preincubation of polysomes on inhibition of 
puromycin peptide formation by cycloheximide and other 
related antibiotics. 
Antibiotic added upmoles puromycin 
(amount/ml) peptide/mg ribosomes 
Not preincubated Preincubated 
None 29.0 29.3 
Cycloheximide (1 mg) 7.5 27.1 
Fusidic acidic (600 rg) 6.7 28.3 
Emetine (100 pg) 28.5 28.3 
Sparsomycin (2 pg) 3.5 4.2 
The reaction mixture contained, in a total volume of 0.5 ml 
of 50 mM tris-HCl pH 7.6, 10 mM MgCla, 300 mM NH&l, 
together with 0.5 mpmoles 3H-puromycin (3 X 10’ cgm) and 
0.5 mg polysomes. Incubations were carried out at 37 for 60 
min. When the reaction was carried out in two steps, the poly- 
somes and buffer were preincubated for 5 min. After the pre- 
incubation, additional buffer, 3H-puromycin and the inhibitors 
were added and incubated for a further 50 min. The experi- 
ment was replicated twice. 
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somycin was inhibitory under both conditions. These 
results indicate that cycloheximide and fusidic acid 
inhibit the translocation reaction and not peptide 
bond formation, which is inhibited only by sparso- 
mycin. 
The inhibitory action of cycloheximide in this 
system can be also prevented by addition of exogenous 
transferase II and GTP. Thus, in one series of studies 
under conditions similar to table 1, the synthesis of 
puromycin peptide in /_qmoles per tube was 38.0 for 
the control incubation, 11.6 in presence of cyclohex- 
imide (1 mg/ml), 32.8 in presence of cycloheximide 
and GTI’ (0.2 mM), and 36.2 in presence of cyclo- 
heximide with GTP (0.2 mM) and transferase II 
fraction (100 pg protein/ml). This is further evidence 
that cycloheximide interacts with the translocation 
system. 
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